These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
351 related items for PubMed ID: 12380788
1. Safety and efficacy of cefepime versus ceftazidime in the treatment of severe infections. Huang CK, Chen YS, Lee SS, Lin WR, Tsai HC, Lin HH, Wann SR, Chen JY, Yen MY, Liu YC. J Microbiol Immunol Infect; 2002 Sep; 35(3):159-67. PubMed ID: 12380788 [Abstract] [Full Text] [Related]
2. Efficacy and safety of cefepime treatment in Chinese patients with severe bacterial infections: in comparison with ceftazidime treatment. Chang SC, Fang CT, Hsueh PR, Liu CJ, Sheng WH, Hsieh SM, Hung CC, Chen YC. Int J Antimicrob Agents; 1998 Aug; 10(3):245-8. PubMed ID: 9832286 [Abstract] [Full Text] [Related]
3. Randomized comparison of cefepime and ceftazidime for treatment of hospitalized patients with gram-negative bacteremia. Schrank JH, Kelly JW, McAllister CK. Clin Infect Dis; 1995 Jan; 20(1):56-8. PubMed ID: 7727671 [Abstract] [Full Text] [Related]
4. A new therapeutic option for the treatment of pneumonia. McCabe R, Chirurgi V, Farkas SA, Haddow A, Heinz G, Greene S. Am J Med; 1996 Jun 24; 100(6A):60S-67S. PubMed ID: 8678099 [Abstract] [Full Text] [Related]
5. Cefepime/amikacin versus ceftazidime/amikacin as empirical therapy for febrile episodes in neutropenic patients: a comparative study. The French Cefepime Study Group. Cordonnier C, Herbrecht R, Pico JL, Gardembas M, Delmer A, Delain M, Moreau P, Ladeb S, Nalet V, Rollin C, Gres JJ. Clin Infect Dis; 1997 Jan 24; 24(1):41-51. PubMed ID: 8994754 [Abstract] [Full Text] [Related]
6. International comparative study of cefepime and ceftazidime in the treatment of serious bacterial infections. Hoepelman AI, Kieft H, Aoun M, Kosmidis J, Strand T, Verhoef J, Gillespie SH, Riddell J, Varghese G, Meunier F. J Antimicrob Chemother; 1993 Nov 24; 32 Suppl B():175-86. PubMed ID: 8150761 [Abstract] [Full Text] [Related]
7. A comparative study of cefepime versus ceftazidime as empiric therapy of febrile episodes in neutropenic patients. Wang FD, Liu CY, Hsu HC, Gau JP, Chau WK, Haung ML, Ho CH. Chemotherapy; 1999 Nov 24; 45(5):370-9. PubMed ID: 10473925 [Abstract] [Full Text] [Related]
8. Cefepime versus ceftazidime in the treatment of lower respiratory tract infections. Aufiero A, Sturani C, Zanon P, Marruchella A, Michetti G, Nicolin E, Sella D, Goglio A, Silleni M, La Regina A. J Chemother; 1997 Jun 24; 9(3):213-8. PubMed ID: 9210005 [Abstract] [Full Text] [Related]
9. Cefepime versus ceftazidime for the treatment of serious bacterial infections. Ponce-de-León A, López-Meneses M, Sifuentes-Osornio J. Diagn Microbiol Infect Dis; 1999 Dec 24; 35(4):263-8. PubMed ID: 10668583 [Abstract] [Full Text] [Related]
13. Comparative study of cefepime versus ceftazidime in the empiric treatment of pediatric cancer patients with fever and neutropenia. Mustafa MM, Carlson L, Tkaczewski I, McCracken GH, Buchanan GR. Pediatr Infect Dis J; 2001 Mar 24; 20(3):362-9. PubMed ID: 11303851 [Abstract] [Full Text] [Related]
14. A randomized, double-blind trial comparing ceftobiprole medocaril with vancomycin plus ceftazidime for the treatment of patients with complicated skin and skin-structure infections. Noel GJ, Bush K, Bagchi P, Ianus J, Strauss RS. Clin Infect Dis; 2008 Mar 01; 46(5):647-55. PubMed ID: 18225981 [Abstract] [Full Text] [Related]
15. Cefpirome versus ceftazidime in the treatment of urinary tract infections. J Antimicrob Chemother; 1992 Apr 01; 29 Suppl A():95-104. PubMed ID: 1601765 [Abstract] [Full Text] [Related]
20. The efficacy and safety of isepamicin and ceftazidime compared with amikacin and ceftazidime in acute lower respiratory tract infection. Colardyn F. J Chemother; 1995 Jun 01; 7 Suppl 2():129-35. PubMed ID: 8622101 [Abstract] [Full Text] [Related] Page: [Next] [New Search]